In this issue of The Journal of Infectious Diseases, Stephen Arnon and colleagues report on the discovery and partial molecular characterization of a novel Clostridium botulinum toxin, the first to be recognized in more than 40 years. The 2 articles describing these findings are accompanied by 2 editorials, one by Popoff describing the historical context and scientific importance of the observations, and the other by Relman discussing the issues related to dual use research of concern (DURC) raised by these articles.
As mentioned in a previous editorial commentary accompanying an article that raised DURC issues [1, 2] , journal decisions on what information to publish and what to withhold are complicated, and must measure the public's right to know and the free flow of scientific information with national and international security needs. The decision was made to publish the current reports because they represent outstanding science and are of great importance to the fields of infectious diseases and public health. The decision to withhold certain genetic information was more complex. It is general JID policy that gene nucleotide sequences must be submitted to the International Nucleotide Sequence Databases and that the accession numbers must appear in the final revision and published version of the manuscript. However, in this case, we made an exception. Because no antitoxins as yet have been developed to counteract the novel C. botulinum toxin, the authors had detailed consultations with representatives from numerous appropriate US government agencies (see Notes), as well as the JID editors, and received approval to publish both manuscripts, while withholding the key gene sequences until appropriate countermeasures were developed.
The Journal of Infectious Diseases will continue to scrutinize each submitted manuscript for possible DURC issues. We have implemented a policy asking reviewers to help us identify manuscripts that might raise such concerns. Each situation will be handled in a case-by-case manner, and we will continue to closely monitor this ever-evolving field. 
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